Primogene is a biotechnology company that provides ingredient development, bioprocess manufacturing, and scalable production.
Primogene has raised $4.8M in total funding. The most recent round was Seed. The last funding was announced in April 2026.
Primogene's investors include HTGF (High-Tech Gruenderfonds), better ventures, TGFS - Technologiegründerfonds Sachsen, FS Life Science Investment, Golzern Holding GmbH.
Primogene is headquartered in Leipzig, Germany.
Primogene is a biotechnology company that provides ingredient development, bioprocess manufacturing, and scalable production.
Primogene is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Primogene — Funding & Investors." VCBacked, April 29, 2026, https://www.vcbacked.co/company/primogene. Accessed October 21, 2026.
VCBacked. (2026). Primogene — Funding & Investors. Retrieved October 21, 2026, from https://www.vcbacked.co/company/primogene
{{cite web |title=Primogene — Funding & Investors |url=https://www.vcbacked.co/company/primogene |website=VCBacked |access-date=October 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated